Company Search:
Advanced Search
Sponsored Links
Ovid Therapeutics Inc Company Snapshot
Ovid Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ovid Therapeutics Inc with three other companies in this sector in UNITED STATES : Kalvista Pharmaceuticals Inc (2020 sales of $12.69 million of which 100% was Pharmaceuticals), Inhibrx Inc ($12.89 million of which 100% was Biologic therapeutic candidates), and Cidara Therapeutics Inc ($12.07 million of which 100% was Care therapies).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ovid Therapeutics Inc
  Stock Performance Chart for Ovid Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 3.67
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks -9.8%  
4 Weeks 30.6%   52 Weeks 10.5%  
Ovid Therapeutics Inc Key Data:
  Ticker: OVID Country: United States
  Exchanges: NYSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 12,617,221
(Year Ending Jan 2021).
Employees: 67
  Currency: U.S. Dollars Market Cap: 241,277,434
  Fiscal Yr Ends: December Shares Outstanding: 65,743,170
  Share Type: Common Closely Held Shares: 22,154,257
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.